疑似上尿路尿路上皮癌冷冻活检的前瞻性可行性研究
本研究在10例疑似上尿路尿路上皮癌患者中行输尿管软镜活检,共80次(冷冻活检28次、钳夹28次、网篮24次),主要终点为冷冻活检诊断率。冷冻活检全部获得明确病理诊断,诊断样本比例及代表性样本比例均高于钳夹和网篮,标本面积更大,术后血尿可保守处理。
要点
- 冷冻活检在肾盂肿瘤中可行,全部患者获得明确病理诊断。
- 冷冻活检诊断样本比例75.0%,高于钳夹35.7%和网篮29.2%。
- 冷冻活检标本面积18.0 mm²,大于钳夹6.4 mm²和网篮9.6 mm²。
核心结论
- 肾盂冷冻活检可行,标本更大、质量更高,但能否改善分期或治疗选择需更大规模多中心试验验证。
研究设计与样本
- 前瞻性可行性研究,连续纳入10例疑似上尿路尿路上皮癌的肾盂肿瘤患者,共获取80次活检(冷冻活检28次、钳夹28次、网篮24次)。
主要发现
- 冷冻活检使全部患者获得明确组织病理学诊断(主要终点)。
- 诊断性冷冻样本比例75.0%,显著高于钳夹35.7%(p=0.007)和网篮29.2%(p=0.002)。
- 代表性样本比例冷冻活检82.1%,高于钳夹46.4%(p=0.011)和网篮54.2%(p=0.038)。
- 冷冻活检平均面积18.0 mm²,大于钳夹6.4 mm²(p<0.001)和网篮9.6 mm²(p=0.008)。
- 组织学可评估性评分冷冻活检4.8,高于钳夹2.9(p=0.031),与网篮3.8比较p>0.999。
关键数值与推荐
- 诊断样本比例:冷冻活检75.0% vs 钳夹35.7%(p=0.007)vs 网篮29.2%(p=0.002)。
- 代表性样本比例:冷冻活检82.1% vs 钳夹46.4%(p=0.011)vs 网篮54.2%(p=0.038)。
- 平均标本面积:冷冻活检18.0 mm² vs 钳夹6.4 mm²(p<0.001)vs 网篮9.6 mm²(p=0.008)。
- 组织学可评估性评分:冷冻活检4.8 vs 钳夹2.9(p=0.031)vs 网篮3.8(p>0.999)。
临床怎么用
- 在疑似上尿路尿路上皮癌的输尿管软镜活检中,可考虑使用冷冻活检以提高标本质量和诊断率。
- 术后血尿常见但多可保守处理,本研究中无患者需输血或再干预。
局限性
- 样本量小(10例患者),为单中心前瞻性可行性研究。
- 冷冻活检是否改善分期、风险分层或治疗选择尚未证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility and specimen quality of cryobiopsy for ureterorenoscopic (URS) biopsy in suspected upper tract urothelial carcinoma (UTUC). METHODS: Using a newly developed flexible cryoprobe, a total of 80 biopsies were obtained in 10 consecutive patients with renal pelvis tumors suspicious for UTUC (cryobiopsy, n = 28; forceps, n = 28; basket, n = 24). The primary endpoint was the diagnostic yield of cryobiopsy; secondary endpoints included comparison with standard instruments, feasibility, safety, and specimen quality. RESULTS: Cryobiopsy enabled a definitive histopathological diagnosis in all patients (primary endpoint). As a secondary endpoint, the percentage of diagnostic cryosamples was significantly higher than with conventional forceps (75.0% vs. 35.7%; p=0.007) or basket biopsy (29.2%; p=0.002). The proportion of representative samples was highest with cryobiopsy (82.1%) compared with forceps (46.4%, p = 0.011) and basket biopsy (54.2%, p = 0.038). Cryobiopsies were significantly larger (mean area 18.0 mm²) than forceps (6.4 mm², p<0.001) or basket specimens (9.6 mm², p=0.008). Histological assessability was highest with cryobiopsy (score 4.8 vs. 2.9 with forceps, p = 0.031, and 3.8 with basket, p > 0.999). Postoperative hematuria occurred in six of ten patients; it was managed conservatively, and no patient required transfusion or re-intervention. CONCLUSIONS: Cryobiopsy in the renal pelvis is feasible and yielded larger, higher-quality specimens than standard instruments. Whether this improves staging, risk stratification, or treatment selection requires larger multicenter trials (trial registration number DRKS00025620).
引用
- Bolenz C, Schockmann J, Klein JT, et al. Prospective feasibility study of cryobiopsy in patients with suspected upper tract urothelial carcinoma. Urology. 2026. PMID: 42893752. doi:10.1016/j.urology.2026.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。